Bevacizumab for Central Retinal Vein Occlusion Study
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
Central retinal vein occlusion is a leading cause of severe visual impairment. Until now, no
treatment has been available to improve visual acuity. The present study intends to
investigate if intravitreal bevacizumab can improve visual acuity as compared to sham-treated
control patients.